» Articles » PMID: 26245868

Neuroinflammatory Responses in Diabetic Retinopathy

Overview
Publisher Biomed Central
Date 2015 Aug 7
PMID 26245868
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR) is a common complication of diabetes and has been recognized as a vascular dysfunction leading to blindness in working-age adults. It becomes increasingly clear that neural cells in retina play an important role in the pathogenesis of DR. Neural retina located at the back of the eye is part of the brain and a representative of the central nervous system. The neurosensory deficits seen in DR are related to inflammation and occur prior to the clinically identifiable vascular complications. The neural deficits are associated with abnormal reactions of retina glial cells and neurons in response to hyperglycemia. Improper activation of the innate immune system may also be an important contributor to the pathophysiology of DR. Therefore, DR manifests characteristics of both vasculopathy and chronic neuroinflammatory diseases. In this article, we attempt to provide an overview of the current understanding of inflammation in neural retina abnormalities in diabetes. Inhibition of neuroinflammation may represent a novel therapeutic strategy to the prevention of the progression of DR.

Citing Articles

Targeting tRNA-Derived Non-Coding RNA Alleviates Diabetes-Induced Visual Impairment through Protecting Retinal Neurovascular Unit.

Yao J, Yao W, Zhu J, Liu Y, Liu J, Ji Y Adv Sci (Weinh). 2024; 12(1):e2411042.

PMID: 39513253 PMC: 11714213. DOI: 10.1002/advs.202411042.


Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review.

Gholami M, Coleman-Fuller N, Salehirad M, Darbeheshti S, Motaghinejad M Int J Prev Med. 2024; 15:28.

PMID: 39239308 PMC: 11376549. DOI: 10.4103/ijpvm.ijpvm_5_23.


Quantification of Photoreceptors' Changes in a Diabetic Retinopathy Model with Two-Photon Imaging Microscopy.

Bautista-Elivar N, Aviles-Trigueros M, Bueno J Int J Mol Sci. 2024; 25(16).

PMID: 39201444 PMC: 11354294. DOI: 10.3390/ijms25168756.


Comparing the efficacy of dexamethasone implant and anti-VEGF for the treatment of macular edema: A systematic review and meta-analysis.

Tang H, Li J, Yuan Y, Ling Y, Mei Z, Zou H PLoS One. 2024; 19(7):e0305573.

PMID: 38985778 PMC: 11236136. DOI: 10.1371/journal.pone.0305573.


Single-cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy.

Zhang X, Zhang F, Xu X Clin Transl Med. 2024; 14(7):e1751.

PMID: 38946005 PMC: 11214886. DOI: 10.1002/ctm2.1751.


References
1.
Yoshida A, Yoshida S, Ishibashi T, Kuwano M, Inomata H . Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice. Invest Ophthalmol Vis Sci. 1999; 40(7):1624-9. View

2.
Lu M, Perez V, Ma N, Miyamoto K, Peng H, Liao J . VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999; 40(8):1808-12. View

3.
Limb G, Hollifield R, CHIGNELL A . Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999; 40(10):2453-7. View

4.
Duh E, Aiello L . Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes. 1999; 48(10):1899-906. DOI: 10.2337/diabetes.48.10.1899. View

5.
Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan P, Koistinaho J . A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A. 1999; 96(23):13496-500. PMC: 23976. DOI: 10.1073/pnas.96.23.13496. View